European Commission secures EU access to Remdesivir for treatment of COVID-19
Date of publication: 29-07-2020
The European Commission has signed a contract with the pharmaceutical company Gilead to secure treatment doses of Veklury, the brand name for Remdesivir. Veklury was the first medicine authorised at EU level for treatment of COVID-19. Źródło: https://ec.europa.eu
